JMV 176
Product Specifications
UNSPSC Description
Jmv 176 is a CCK agonist when first given and becomes a cholecystokinin antagonist after 3-4 hours[1].
Target Antigen
Cholecystokinin Receptor
Type
Peptides
Related Pathways
GPCR/G Protein;Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/jmv-176.html
Smiles
O=C(NC(CC1=CC=C(C=C1)OS(=O)(O)=O)C(NC(CCCC)C(CCC(NC(CC2=CNC3=C2C=CC=C3)C(NC(CCCC)C(NC(CC(O)=O)C(NC(CC4=CC=CC=C4)C(N)=O)=O)=O)=O)=O)=O)=O)OC(C)(C)C
Molecular Weight
1091.23
References & Citations
[1]Gourch A, et al. A cholecystokinin agonist/antagonist according to dose and time of action: effect on food intake. Neuropeptides. 1990 Dec;17(4):187-91.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P2121/JMV-176-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P2121/
Clinical Information
No Development Reported
CAS Number
119068-32-5
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
18674126 3 x 1.0μg DNA
DUSP13 CRISPRa sgRNA lentivector (set of three targets)(Rat)
Ask
View Details 
